40 years experience; SVP, Global Sales & Marketing for Digene Corp from IPO to acquisition by QIAGEN NV (in 2007) creating market & technology leader in molecular Dx. Then, Senior Advisor/Molecular Diagnostics for Developing World at QIAGEN. Consultant to John D Rockefeller 3rd Fund, 23andMe, ImpediMed Pty Ltd, Vertex Pharma, OpGen.
35 years experience; business executive, General Manager, CEO of UniQuest, MSI, Genetrax. Founding CEO of Immunexpress, directly responsible for driving capital, business and technology development to date. Raised over $40 million in high risk dilutive equity capital and non-dilutive grant funding over the last 10 years.
35 years experience – medical devices and in-vitro-diagnostics. International roles for Baxter Diagnostics (Australia & UK), Senior Global Marketing Manager for Roche Molecular Systems, and VP Global Strategic Marketing for Digene Corp. Managing Director and CEO for ImpediMed Limited. Boards: StraxCorp, Minomic, UniQuest.
25 years experience in sales, marketing and business development for technology developers and the pharmaceutical industry – BioRad Laboratories, Gnothis SA, Debiopharm Innovation Fund. Currently Associate Director at Debiopharm Innovation Fund, Switzerland; actively involved in managing and growing diagnostic investment portfolio.